首站-论文投稿智能助手
典型文献
Effects of Omega-3 Fatty Acids on Chinese Patients with Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis
文献摘要:
Objective::Fish oil (FO) contains omega-3 that inhibits inflammation and blood lipid metabolism, giving it a protective cardiovascular effect. Due to dietary habits, a majority of large-scale clinical trials examining FO and cardiovascular health have been conducted in the Caucasian populations. However, the effects of FO on cardiovascular inflammation indicators and blood lipid metabolism in the Chinese population remain unclear. This study aimed to perform a meta-analysis to elucidate the impact of FO on cardiovascular health in the Chinese population.Methods::Web searches were utilized to locate records of clinical trials related to cardiovascular health and consumption of FO capsules or fish containing omega-3 in several databases, including PubMed, Medline, Embase, Cochrane Library, CNKI, and ClinicalTrial.gov, etc. We obtained lipid metabolism and related proinflammatory markers as the study outcome. We used Review Manager 5.4 and Stata 16 for the statistical analysis. If the I2 ≥ 30%, a random effects model was used, and if the I2 < 30%, a fixed effects model was used. Results::Twenty eligible trials were shortlisted from >1000 records. The meta-analysis revealed that supplementation with eicosapentaenoic acid and docosahexaenoic acid reduced systolic blood pressure by 1.88 mmHg (95% CI: -4.97 to -1.20, P = 0.23), diastolic blood pressure by 0.86 mmHg (95% CI: -1.79 to 0.06, P = 0.07), fasting blood glucose by 0.05 mmol/L (95% CI: -0.16 to 0.06, P = 0.40), and low-density lipoprotein-cholesterol by 0.12 mmol/L (95% CI: -0.23 to -0.01, P = 0.04), when compared to placebo. However, these supplements increased high-density lipoprotein-cholesterol by 0.03 mmol/L (95% CI: 0.01 to 0.05, P < 0.001), when compared to placebo. Dose subgroup analyses examining total cholesterol found that the low-dose group (mean difference = -0.44, 95% CI: -0.55 to -0.34, P < 0.001) demonstrated the best results. Further, results from dose subgroup analyses showed that the all-dose group demonstrated a decrease in tumor necrosis factor (TNF-α) levels among the study subjects, when compared to other groups. Conclusions::Consumption of FO containing omega-3 fatty acids in the Chinese population can improve lipid metabolism and reduce levels of proinflammatory markers. Therefore, it is necessary to vigorously promote the benefits of consuming FO to prevent cardiovascular diseases throughout China.
文献关键词:
Chinese population;Fish oil;Lipid metabolism;Meta-analysis;Omega-3;Proinflammatory markers
作者姓名:
Mei Zhu;Song Haixu;Tian Xiaoxiang;Liu Dan
作者机构:
Department of Cardiology and Cardiovascular Research Institute, General Hospital of Northern Theater Command, Shenyang, Liaoning 110016, China
引用格式:
[1]Mei Zhu;Song Haixu;Tian Xiaoxiang;Liu Dan-.Effects of Omega-3 Fatty Acids on Chinese Patients with Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis)[J].心血管病探索(英文),2022(01):22-29
A类:
ClinicalTrial,shortlisted,Proinflammatory
B类:
Effects,Omega,Fatty,Acids,Chinese,Patients,Cardiovascular,Risk,Factors,Systematic,Review,Analysis,Objective,Fish,oil,FO,contains,omega,that,inhibits,inflammation,blood,lipid,metabolism,giving,protective,cardiovascular,Due,dietary,habits,majority,large,scale,clinical,trials,examining,health,have,been,conducted,Caucasian,populations,However,effects,indicators,remain,unclear,This,study,aimed,perform,analysis,elucidate,impact,Methods,searches,were,utilized,locate,records,related,consumption,capsules,fish,containing,several,databases,including,Medline,Embase,Cochrane,Library,gov,etc,obtained,proinflammatory,markers,outcome,used,Manager,Stata,statistical,If,I2,random,model,was,fixed,Results,Twenty,eligible,from,revealed,supplementation,eicosapentaenoic,docosahexaenoic,reduced,systolic,pressure,by,mmHg,diastolic,fasting,glucose,low,density,lipoprotein,cholesterol,when,compared,placebo,these,supplements,increased,high,Dose,subgroup,analyses,total,found,dose,mean,difference,demonstrated,best,results,Further,showed,all,decrease,tumor,necrosis,levels,among,subjects,other,groups,Conclusions,Consumption,fatty,acids,can,improve,Therefore,necessary,vigorously,promote,benefits,consuming,prevent,diseases,throughout,China,Lipid
AB值:
0.524238
相似文献
Association Between Lipid Profiles and Left Ventricular Hypertrophy: New Evidence from a Retrospective Study
Xuewei Huang;Keqiong Deng;Juanjuan Qin;Fang Lei;Xingyuan Zhang;Wenxin Wang;Lijin Lin;Yuming Zheng;Dongai Yao;Huiming Lu;Feng Liu;Lidong Chen;Guilan Zhang;Yueping Liu;Qiongyu Yang;Jingjing Cai;Zhigang She;Hongliang Li-Department of Cardiology,Renmin Hospital of Wuhan University,Wuhan 430060,China;Physical Examination Center,Zhongnan Hospital of Wuhan University,Wuhan 430071,China;Department of Cardiology,Center Hospital of Huanggang,Huanggang,Hubei 438000,China;Huanggang Institute of Translation Medicine,Huanggang,Hubei 438000,China;Department of Cardiology;Institute of Model Animal;School of Basic Medical Science,Wuhan University,Wuhan 430071,China;Physical Examination Center,The Central Hospital of Wuhan,Wuhan 430014,China;General Medical Department,CR&WISCO General Hospital,Wuhan 430000,China;Information Center,Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Wuhan 430015,China;Department of Medical Examination Center,Taihe Hospital,Hubei University of Medicine,Shiyan,Hubei 442000,China;Department of Health Management,Xiaogan Hospital Affiliated to Wuhan University of Science and Technology,Xiaogan,Hubei 432000,China;Basic Medical Laboratory,General Hospital of Central Theater Command,Wuhan 430070,China;Hubei Key Laboratory of Central Nervous System Tumor and Intervention,Wuhan 430070,China;Chinese Medicine Center,Shiyan Renmin Hospital,Shiyan,Hubei 442000,China;Department of Cardiology,The Third Xiangya Hospital,Central South University,Changsha 410000,China
Role of blood pressure on stroke-related mortality: a 45-year follow-up study in China
Wang Shengshu;Yang Shanshan;Jia Wangping;Han Ke;Song Yang;Zeng Jing;Cao Wenzhe;Liu Shaohua;Chen Shimin;Li Zhiqiang;Li Xuehang;Tai Penggang;Kou Fuyin;He Yao;Liu Miao-Institute of Geriatrics, Beijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, Second Medical Center of Chinese PLA General Hospital, Beijing 100853, China;Department of Healthcare, Agency for Offices Administration, Central Military Commission, Beijing 100082, China;Department of Disease Prevention and Control, The 1st Medical Center, Chinese PLA General Hospital, Beijing 100853, China;Department of Endocrinology, Beijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, Second Medical Center of Chinese PLA General Hospital, Beijing 100853, China;Department of Medical Service, Chinese People’s Liberation Army General Hospital, Beijing 100853, China;Department of Epidemiology, State Key Laboratory of Kidney Diseases, Chinese People’s Liberation Army General Hospital, Beijing 100853, China;Graduate School of Chinese PLA General Hospital, Beijing 100853, China
Risk of gestational diabetes recurrence and the development of type 2 diabetes among women with a history of gestational diabetes and risk factors: a study among 18 clinical centers in China
Wei Yumei;Juan Juan;Su Rina;Song Geng;Chen Xu;Shan Ruiqin;Li Ying;Cui Shihong;Fan Shangrong;Feng Ling;You Zishan;Meng Haixia;Cai Yan;Zhang Cuilin;Yang Huixia-Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China;Department of Obstetrics, Tianjin Central Obstetrics and Gynecology Hospital, Tianjin 300199, China;Department of Obstetrics, Jinan Maternal and Child Health Hospital, Jinan, Shandong 250000, China;Department of Obstetrics, Dalian Maternity Hospital, Dalian, Liaoning 116033, China;Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China;Department of Obstetrics, Shenzhen Peking University Hospital, Shenzhen, Guangdong 518036, China;Department of Obstetrics and Gynecology, Tongji Hospital Affiliated to Huazhong University of Science and Technology, Wuhan, Hubei 430030, China;Department of Obstetrics and Gynecology, Suzhou Jiulong Hospital Affiliated to Shanghai Jiaotong University, Suzhou, Jiangsu 320571, China;Department of Obstetrics, Affiliated Hospital of Inner Mongolia Medical University, Huhhot, Inner Mongolia 010050, China;Department of Obstetrics and Gynecology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China;Epidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20817, USA
Estimating global prevalence, incidence, and outcomes of non-alcoholic fatty liver disease from 2000 to 2021: systematic review and meta-analysis
Liu Jiaye;Tian Ye;Fu Xia;Mu Chunyang;Yao Menglin;Ni Yinyun;Liu Yong;Li Zhihui-Department of Thyroid and Parathyroid Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, China;Laboratory of Thyroid and Parathyroid Diseases, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, China;State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan 610000, China;Respiratory Health Institute, Frontiers Science Center for Disease Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, China;Department of Ultrasound, West China Hospital of Sichuan University, Chengdu, Sichuan 610000, China;Department of Outpatients, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, China;Department of Liver Surgery and Liver Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, China;Department of Gastroenterological Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, China
Ultra-performance Liquid Chromatography-Quadrupole/Time-of-Flight Mass Spectrometry Based Bile and Urine Metabonomics Study on the Ameliorative Effects of Curcuma wenyujin Rhizoma on Acute Blood Stasis in Rats
Min Hao;Meng-Ting Zhao;Huang-Jin Tong;De Ji;Lin Li;Lian-Lin Su;Wei Gu;Chun-Qin Mao;Tu-Lin Lu-Chinese Medicine Processing Engineering Center,School of Pharmaceutical Sciences,Zhejiang Chinese Medical University,Hangzhou,China;Chinese Medicine Processing Laboratory,School of Pharmacy,Guizhou University of Traditional Chinese Medicine,Guizhou,China;Department of Pharmacy,Affiliated Hospital of Integrated Traditional Chinese and Western Medicine,Nanjing University of Chinese Medicine,Nanjing,China;Chinese Medicine Processing Laboratory,College of Pharmacy,Nanjing University of Chinese Medicine,Nanjing,China
Head Acupuncture Plus Schuell's Language Rehabilitation for Post-Stroke Aphasia:A Systematic Review and Meta-Analysis of 32 Randomized Controlled Trials
FU Qin-wei;LIU Miao;ZHANG Lan-zhi;YANG Hui;ZHANG Le-qi;YANG Sha-sha;XIE Yan;WAN Xin-xin;TANG Yong;ZHANG Qin-xiu-Department of Otolaryngology,Hospital of Chengdu University of Traditional Chinese Medicine,Chengdu(610075),China;Department of Gastroenterology,Hospital of Chengdu University of Traditional Chinese Medicine,Chengdu(610075),China;Department of Medical Cosmetology,Hospital of Chengdu University of Traditional Chinese Medicine,Chengdu(610075),China;Department of Endocrinology,Hospital of Chengdu University of Traditional Chinese Medicine,Chengdu(610075),China;OCD Institute,McLean Hospital,Boston(02346),USA;Mental Health Counseling,Lynch School of Education,Boston College,Boston(02346),USA;Department of Otolaryngology,The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine,Guiyang(550005),China;Sydney School of Education and Social Work,The University of Sydney,Sydney(2006),Australia;Acupuncture and Tuina School,Chengdu University of Traditional Chinese Medicine,Chengdu(610075),China;School of Medical and Life Sciences,Chengdu University of Traditional Chinese Medicine,Chengdu(611137),China;World Health Organization Collaborating Centre(WHOCC)-CHN-56,Chengdu(611137),China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。